Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1996-07-10
1997-09-16
Bernhardt, Emily
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514253, 544376, 544391, 544398, A61K 31495, C07D295092, C07D295185, C07D40906
Patent
active
056681380
ABSTRACT:
A compound selected from those of formula (I): ##STR1## where RA, RB, RC, RD, A, n, X, Y and Ar are defined in the description, and a medicinal product comprising the same for treating a mammal afflicted with a disease associated with sigma receptors.
REFERENCES:
Gerwitz et al., Neuropsycho Pharmacology10, p. 37-40 (1994).
Kanebo, Chemical Abstracts, vol. 94, No. 121587 (1981) (Abstract for JP 80 83, 773 Jun. 24, 1980).
Zikolova, Chemical Abstractsvol. 96, No. 162653 (1982).
Georgiev, Chemical Abstracts, vol. 99, No. 16105 (1983).
Baziard-Mouysset Genevieve
Caignard Daniel-Henri
Labssita Youssef
Payard Marc
Renard Pierre
Adir et Compagnie
Bernhardt Emily
LandOfFree
Phenoyalkylpiperazine derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Phenoyalkylpiperazine derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Phenoyalkylpiperazine derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-218464